FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313680611> ?p ?o ?g. }

• W4313680611 endingPage "86" @default.
• W4313680611 startingPage "77" @default.
• W4313680611 abstract "Many patients with resected American Joint Committee on Cancer (AJCC) early-stage cutaneous melanoma nonetheless die of melanoma; additional risk stratification approaches are needed.Using prospectively-collected whole-tissue sections, we assessed in consecutive stage I-IIA patients (N = 439), a previously-validated, immunohistochemistry-based, 7-biomarker signature to prognosticate disease-free survival (DFS), melanoma-specific survival (MSS; primary end-point) and overall survival (OS), independent of AJCC classification.Seven-marker signature testing designated 25.1% of patients (110/439) as high-risk (stage IA, 13.3% [43/323], IB, 53.2% [42/79], and IIA, 67.6% [25/37]). A Kaplan-Meier analysis demonstrated high-risk patients to have significantly worse DFS, MSS and OS versus low-risk counterparts (P < 0.001). In multivariable Cox regression modelling also including key clinicopathological/demographic factors, 7-marker signature data independently prognosticated the studied end-points. Models with the 7-marker signature risk category plus clinicopathological/demographic covariates substantially outperformed models with clinicopathological/demographic variables alone in predicting all studied outcomes (areas under the receiver operator characteristic curve 74.1% versus 68.4% for DFS, 81.5% versus 71.2% for MSS, 80.9% versus 73.0% for OS; absolute differences 5.7%, 10.3% and 7.9%, respectively, favouring 7-marker signature risk category-containing models).In patients with AJCC early-stage disease, the 7-marker signature reliably prognosticates melanoma-related outcomes, independent of AJCC classification, and provides a valuable complement to clinicopathological/demographic factors." @default.
• W4313680611 created "2023-01-08" @default.
• W4313680611 creator A5001548963 @default.
• W4313680611 creator A5004598911 @default.
• W4313680611 creator A5017065613 @default.
• W4313680611 creator A5019103554 @default.
• W4313680611 creator A5023555916 @default.
• W4313680611 creator A5025256131 @default.
• W4313680611 creator A5040679537 @default.
• W4313680611 creator A5082116571 @default.
• W4313680611 creator A5084483753 @default.
• W4313680611 date "2023-03-01" @default.
• W4313680611 modified "2023-10-18" @default.
• W4313680611 title "Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma" @default.
• W4313680611 cites W1536661195 @default.
• W4313680611 cites W2009434058 @default.
• W4313680611 cites W2020016182 @default.
• W4313680611 cites W2067391421 @default.
• W4313680611 cites W2073618702 @default.
• W4313680611 cites W2073852133 @default.
• W4313680611 cites W2113499049 @default.
• W4313680611 cites W2136974022 @default.
• W4313680611 cites W2152873514 @default.
• W4313680611 cites W2206673145 @default.
• W4313680611 cites W2231890170 @default.
• W4313680611 cites W2341687551 @default.
• W4313680611 cites W2523491033 @default.
• W4313680611 cites W2552082190 @default.
• W4313680611 cites W2762347490 @default.
• W4313680611 cites W2776187748 @default.
• W4313680611 cites W2896455132 @default.
• W4313680611 cites W2941073668 @default.
• W4313680611 cites W2952857864 @default.
• W4313680611 cites W2968577781 @default.
• W4313680611 cites W2996093895 @default.
• W4313680611 cites W2997216818 @default.
• W4313680611 cites W3023729455 @default.
• W4313680611 cites W3093657026 @default.
• W4313680611 cites W3111747864 @default.
• W4313680611 cites W3162992789 @default.
• W4313680611 cites W3171883446 @default.
• W4313680611 cites W3198857831 @default.
• W4313680611 cites W4211167669 @default.
• W4313680611 cites W4213337365 @default.
• W4313680611 cites W4229079437 @default.
• W4313680611 cites W4283029131 @default.
• W4313680611 doi "https://doi.org/10.1016/j.ejca.2023.01.002" @default.
• W4313680611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36753835" @default.
• W4313680611 hasPublicationYear "2023" @default.
• W4313680611 type Work @default.
• W4313680611 citedByCount "1" @default.
• W4313680611 crossrefType "journal-article" @default.
• W4313680611 hasAuthorship W4313680611A5001548963 @default.
• W4313680611 hasAuthorship W4313680611A5004598911 @default.
• W4313680611 hasAuthorship W4313680611A5017065613 @default.
• W4313680611 hasAuthorship W4313680611A5019103554 @default.
• W4313680611 hasAuthorship W4313680611A5023555916 @default.
• W4313680611 hasAuthorship W4313680611A5025256131 @default.
• W4313680611 hasAuthorship W4313680611A5040679537 @default.
• W4313680611 hasAuthorship W4313680611A5082116571 @default.
• W4313680611 hasAuthorship W4313680611A5084483753 @default.
• W4313680611 hasBestOaLocation W43136806111 @default.
• W4313680611 hasConcept C10515644 @default.
• W4313680611 hasConcept C121608353 @default.
• W4313680611 hasConcept C126322002 @default.
• W4313680611 hasConcept C141341695 @default.
• W4313680611 hasConcept C143998085 @default.
• W4313680611 hasConcept C146357865 @default.
• W4313680611 hasConcept C151730666 @default.
• W4313680611 hasConcept C185592680 @default.
• W4313680611 hasConcept C203092338 @default.
• W4313680611 hasConcept C2777658100 @default.
• W4313680611 hasConcept C2777982462 @default.
• W4313680611 hasConcept C2781197716 @default.
• W4313680611 hasConcept C502942594 @default.
• W4313680611 hasConcept C50382708 @default.
• W4313680611 hasConcept C535046627 @default.
• W4313680611 hasConcept C55493867 @default.
• W4313680611 hasConcept C58471807 @default.
• W4313680611 hasConcept C71924100 @default.
• W4313680611 hasConcept C86803240 @default.
• W4313680611 hasConceptScore W4313680611C10515644 @default.
• W4313680611 hasConceptScore W4313680611C121608353 @default.
• W4313680611 hasConceptScore W4313680611C126322002 @default.
• W4313680611 hasConceptScore W4313680611C141341695 @default.
• W4313680611 hasConceptScore W4313680611C143998085 @default.
• W4313680611 hasConceptScore W4313680611C146357865 @default.
• W4313680611 hasConceptScore W4313680611C151730666 @default.
• W4313680611 hasConceptScore W4313680611C185592680 @default.
• W4313680611 hasConceptScore W4313680611C203092338 @default.
• W4313680611 hasConceptScore W4313680611C2777658100 @default.
• W4313680611 hasConceptScore W4313680611C2777982462 @default.
• W4313680611 hasConceptScore W4313680611C2781197716 @default.
• W4313680611 hasConceptScore W4313680611C502942594 @default.
• W4313680611 hasConceptScore W4313680611C50382708 @default.
• W4313680611 hasConceptScore W4313680611C535046627 @default.
• W4313680611 hasConceptScore W4313680611C55493867 @default.
• W4313680611 hasConceptScore W4313680611C58471807 @default.

• next